Ripal J. Shah

Ahmedabad, GJ, IN 
Ahmedabad, GJ, IN 

Overview

Ripal Shah practices practicing medicine in Ahmedabad, India.

His clinical expertise encompasses Fetal and Neonatal Alloimmune Thrombocytopenia, ABO Incompatibility, Hemolytic Disease of the Newborn, and Hemolytic Transfusion Reaction.

He is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Ahmedabad, GJ, India
Other Locations
Vadodara, GJ, India
Ahmedabad, UP, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

15 Total Publications

Documents to procure gamma irradiation chamber and license for operation in blood center.
Documents to procure gamma irradiation chamber and license for operation in blood center.
Journal: Asian journal of transfusion science
Published: October 14, 2023

Frequently Asked Questions about Ripal J. Shah

Is Ripal J. Shah a top-rated expert for Fetal and Neonatal Alloimmune Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Ripal J. Shah is classified as an Experienced expert for Fetal and Neonatal Alloimmune Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ripal J. Shah participate in research or clinical trials?

Yes. Ripal J. Shah has published 15 articles and abstracts on conditions like Fetal and Neonatal Alloimmune Thrombocytopenia. You can view a list of Ripal J. Shah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shah's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile